Have a Little Fun!

Kovanaze Nasal Spray Approved for Dental Anesthesia

This is the first dental anesthetic administered as a nasal spray

St. Renatus announced that the Food and Drug Administration (FDA) has approved Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray, the first dental anesthetic administered as a nasal spray. It is delivered in the nasal cavity to achieve pulpal (tooth nerve) anesthesia when performing a restorative procedure on Teeth 4–13 and A–J in patients weighing ≥40kg.